Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Naso-Sinusal T ALL With Aberrant Expression of CD56 Mimicking NK/T Non Hodgkin Lymphoma

Authors: Marielle Igala, Sofia Marouan, Jennie Okouango Ova, Mouna Lamchahab, Asmae Quessar, Said Benchekroun

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

T-acute lymphoblastic leukemia (T-ALL) represents 25 % of cases of acute lymphoblastic leukemia (ALL) in adults. The clinical presentation is dominated by a elevated number of white blood cells and in immunophenotype the lymphoblasts are generally Tdt positive and variably express CD1a, CD2, CD3, CD4, CD5, CD7, and CD8. NK/T non Hodgkin lymphoma is presented as a single lesion often ulcerated with torpid evolution affecting the nasal cavity, nasopharynx and/or palate. CD56 expression is while characteristic of NK-cells, and is also expressed on a subset of normal T cells. Its expression in ALL does not exclude the diagnosis and seems to be a prognostic factor of this disease. We report the case of a young woman with nasal cavity tumor which was initially diagnosed as T-cell lymphoma. This diagnosis was finally revised to conclude to T-ALL with CD56 aberrant expression.
Literature
1.
go back to reference Borowitz MJ, Chan JKC (2008) T lymphoblastic leukemia/lymphoma. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, vol 4. IARC Press, Lyon, pp 176–178 Borowitz MJ, Chan JKC (2008) T lymphoblastic leukemia/lymphoma. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, vol 4. IARC Press, Lyon, pp 176–178
2.
go back to reference Ferry JA, Quintanilla-Martinez L, Chan JKC et al (2008) Extranodal NK/T-cell lymphoma, nasal type. WHO classification of tumours of haematopoietic and lymphoid tissues, vol 4. IARC Press, Lyon, pp 285–288 Ferry JA, Quintanilla-Martinez L, Chan JKC et al (2008) Extranodal NK/T-cell lymphoma, nasal type. WHO classification of tumours of haematopoietic and lymphoid tissues, vol 4. IARC Press, Lyon, pp 285–288
3.
go back to reference Ravandi F, Cortes J, Estrov Z et al (2002) CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res 26(7):643–649PubMedCrossRef Ravandi F, Cortes J, Estrov Z et al (2002) CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res 26(7):643–649PubMedCrossRef
4.
go back to reference Montero I, Rios E, Parody R et al (2003) CD56 in T-cell acute lymphoblastic leukaemia: a malignant transformation of an early myeloid-lymphoid progenitor? Haematologica 7:26 Montero I, Rios E, Parody R et al (2003) CD56 in T-cell acute lymphoblastic leukaemia: a malignant transformation of an early myeloid-lymphoid progenitor? Haematologica 7:26
5.
go back to reference Dupuis J (2004) Lymphomes non hodgkiniens T et NK périphériques. EMC 2:016 Dupuis J (2004) Lymphomes non hodgkiniens T et NK périphériques. EMC 2:016
6.
go back to reference Goldberg JM, Silverman LB, Levy DE et al (2003) Chilhood T-cell acute lymphoblastic leukemia: the Dana-Farber cancer institute acute lymphoblastic leukemia consortium experience. J Clin Oncol 21:3616–3622PubMedCrossRef Goldberg JM, Silverman LB, Levy DE et al (2003) Chilhood T-cell acute lymphoblastic leukemia: the Dana-Farber cancer institute acute lymphoblastic leukemia consortium experience. J Clin Oncol 21:3616–3622PubMedCrossRef
7.
go back to reference Leandro F, Dalmazzo F, Rafael H et al (2009) The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment. Br J Haematol 144(2):223–229CrossRef Leandro F, Dalmazzo F, Rafael H et al (2009) The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment. Br J Haematol 144(2):223–229CrossRef
8.
go back to reference Fischer L, Gökbuget N, Schwartz S et al (2009) CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy. Haematologica. 94(2):224–229PubMedCrossRefPubMedCentral Fischer L, Gökbuget N, Schwartz S et al (2009) CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy. Haematologica. 94(2):224–229PubMedCrossRefPubMedCentral
Metadata
Title
Naso-Sinusal T ALL With Aberrant Expression of CD56 Mimicking NK/T Non Hodgkin Lymphoma
Authors
Marielle Igala
Sofia Marouan
Jennie Okouango Ova
Mouna Lamchahab
Asmae Quessar
Said Benchekroun
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-014-0449-2

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine